Search

Search Constraints

You searched for: Author/Creator Cragg, Mark S

Search Results

1. Disparity in peripheral and renal B-cell depletion with rituximab in systemic lupus erythematosus: an opportunity for obinutuzumab?. (11th November 2021)

2. Domain binding and isotype dictate the activity of anti-human OX40 antibodies. Issue 2 (21st December 2020)

3. Domain binding and isotype dictate the activity of anti-human OX40 antibodies. Issue 2 (21st December 2020)

4. Expression of the inhibitory Fc gamma receptor IIB (FCGR2B, CD32B) on follicular lymphoma cells lowers the response rate to rituximab monotherapy (SAKK 35/98). (21st August 2014)

5. Fc-null anti-PD-1 monoclonal antibodies deliver optimal checkpoint blockade in diverse immune environments. Issue 1 (11th January 2022)

6. FcγRII (CD32) modulates antibody clearance in NOD SCID mice leading to impaired antibody-mediated tumor cell deletion. Issue 1 (17th June 2020)

8. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Issue 1 (2nd January 2016)